Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q3 2023 · 145 positions · Total reported value $2.38B · Top-10 concentration 32.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, Invenomic Capital Management LP disclosed 145 equity positions with a combined reported value of $2.38B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 32.1% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2023 were SPY ($235.11M), AAPL ($85.61M), VTRS ($68.55M). By sector, the heaviest allocations are Technology 18.0%, Consumer Discretionary 17.8%.

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions.

The largest new positions opened in Q3 2023 were SPY ($235.11M), AAPL ($85.61M), VTRS ($68.55M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • SPY STATE STR SPDR S&P 500 ETF T · $235.11M
  • AAPL APPLE INC · $85.61M
  • VTRS VIATRIS INC · $68.55M
  • C CITIGROUP INC · $60.03M
  • BMY BRISTOL-MYERS SQUIBB CO · $56.20M
  • WEX WEX INC · $53.70M
  • T AT&T INC · $53.58M
  • SSNC SS&C TECH HLDGS · $50.90M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 18.0%
Financials 5.2%
Energy 4.4%
Other 32.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 550.00K $235.11M 9.88%
9.88%
New
2 500.00K $85.61M 3.60%
3.60%
New
3 6.95M $68.55M 2.88%
2.88%
New
4 1.46M $60.03M 2.52%
2.52%
New
5 968.23K $56.20M 2.36%
2.36%
New
6 285.52K $53.70M 2.26%
2.26%
New
7 3.57M $53.58M 2.25%
2.25%
New
8 968.72K $50.90M 2.14%
2.14%
New
9 7.49M $50.23M 2.11%
2.11%
New
10 714.46K $49.97M 2.10%
2.10%
New
11 1.51M $48.79M 2.05%
2.05%
New
12 1.09M $48.49M 2.04%
2.04%
New
13 280.13K $45.40M 1.91%
1.91%
New
14 1.96M $44.94M 1.89%
1.89%
New
15 996.43K $43.93M 1.84%
1.84%
New
16 170.20K $43.46M 1.83%
1.83%
New
17 3.97M $41.81M 1.76%
1.76%
New
18 398.57K $41.08M 1.73%
1.73%
New
19 300.00K $39.55M 1.66%
1.66%
New
20 644.13K $37.46M 1.57%
1.57%
New
21 2.88M $31.23M 1.31%
1.31%
New
22 388.69K $29.09M 1.22%
1.22%
New
23 949.71K $29.05M 1.22%
1.22%
New
24 251.57K $29.03M 1.22%
1.22%
New
25 5.55M $25.32M 1.06%
1.06%
New
26 3.01M $24.99M 1.05%
1.05%
New
27 352.42K $24.27M 1.02%
1.02%
New
28 1.10M $23.60M 0.99%
0.99%
New
29 583.41K $23.31M 0.98%
0.98%
New
30 1.22M $22.42M 0.94%
0.94%
New
31 544.88K $22.05M 0.93%
0.93%
New
32 345.59K $21.78M 0.92%
0.92%
New
33 2.29M $20.40M 0.86%
0.86%
New
34 534.54K $20.17M 0.85%
0.85%
New
35 1.32M $20.16M 0.85%
0.85%
New
36 2.12M $20.12M 0.84%
0.84%
New
37 521.89K $19.86M 0.83%
0.83%
New
38 1.18M $19.82M 0.83%
0.83%
New
39 616.98K $19.13M 0.80%
0.80%
New
40 1.40M $19.05M 0.80%
0.80%
New
41 265.58K $18.54M 0.78%
0.78%
New
42 1.21M $17.65M 0.74%
0.74%
New
43 5.86M $16.83M 0.71%
0.71%
New
44 2.63M $16.78M 0.70%
0.70%
New
45 954.24K $16.56M 0.69%
0.69%
New
46 1.46M $16.45M 0.69%
0.69%
New
47 968.81K $16.06M 0.68%
0.68%
New
48 355.19K $15.99M 0.67%
0.67%
New
49 244.76K $15.76M 0.66%
0.66%
New
50 2.44M $15.71M 0.66%
0.66%
New

FAQ

What did Invenomic Capital Management LP buy in 2023-Q3?

In its 2023-Q3 13F filing, Invenomic Capital Management LP reported 145 equity positions worth $2.38B in aggregate; its largest disclosed positions were SPY ($235.11M), AAPL ($85.61M), VTRS ($68.55M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $2.38B of long equity holdings across 145 positions as of 2023-Q3. Top-10 holdings account for 32.1% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →